institutionsInstitution
LMU Klinikum München
LMU Klinikum is Munich's university cancer centre, with strengths in PSMA theranostics and haematology.
Comprehensive Cancer Center Munich (with TUM); nuclear medicine leadership in PSMA imaging and therapy.
Location
Munich, DE
Type
university · Ludwig-Maximilians-Universität
Website
Newsweek 2026 oncology rank
#31
OnCo score
#75 · 37 points (29 Newsweek + 0 NCI + 8 from 4 linked objects) · ranking
- Theranostics
- Haematology
Claus Belka
Director, Department of Radiation Oncology, LMU Munich
Radiation oncologyMR-guided radiotherapyRadiobiology
Claus Belka is a radiation oncologist leading MR-guided adaptive radiotherapy research in Munich.
Michael von Bergwelt
Director, Department of Medicine III (Hematology and Oncology), LMU Munich
HaematologyCell therapyImmunotherapy toxicity
Michael von Bergwelt is a haematologist who leads LMU's cell therapy and immuno-oncology programme.
Peter Bartenstein
Director, Department of Nuclear Medicine, LMU Munich
Nuclear medicinePSMA theranosticsNeuro-imaging
Peter Bartenstein is a nuclear medicine head whose department is a leading European PSMA theranostics centre.
Volker Heinemann
Director, Comprehensive Cancer Center Munich (LMU); Professor of Medical Oncology
Colorectal cancerPancreatic cancerAnti-EGFR therapy
Gastrointestinal oncologist who led FIRE-3, a key trial of cetuximab versus bevacizumab in colorectal cancer.